Key Takeaways CRLBF stock gained 25% in a month on federal reform optimism and operational discipline.Cresco is divesting California ops, refinancing $325M debt to ease pressure and boost liquidity.Q2 revenues fell 11$163.6M, with margins squeezed by price compression.Shares of Cresco Labs (CRLBF) , one of the largest vertically integrated, multistate cannabis operators in the United States, have risen 25% over the past month, driven by hopes of federal reform and a strong operational di ...